Page 4,753«..1020..4,7524,7534,7544,755..4,7604,770..»

Category Archives: Transhuman News

Researchers publish improved Neanderthal genome

Posted: March 22, 2013 at 4:44 pm

BERLIN (AP) Researchers in Germany said Tuesday they have completed the first high-quality sequencing of a Neanderthal genome and are making it freely available online for other scientists to study.

The genome produced from remains of a toe bone found in a Siberian cave is far more detailed than a previous draft Neanderthal genome sequenced three years ago by the same team at the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany.

The genome of a Neanderthal is now there in a form as accurate as that of any person walking the streets today, Svante Paabo, a geneticist who led the research, told The Associated Press in an email.

Richard G. Klein, a paleoanthropologist at Stanford University in California who was not involved in the study, said it was a monumental achievement that no one would have thought possible 10 or perhaps even five years ago.

The Leipzig team has already been able to determine which genes the Neanderthal inherited from its mother and which from its father. It now hopes to compare the new genome sequence to that of other Neanderthals, modern humans and Denisovans another extinct human species whose genome was previously extracted from remains found in the same Siberian cave.

We will gain insights into many aspects of the history of both Neanderthals and Denisovans, and refine our knowledge about the genetic changes that occurred in the genomes of modern humans after they parted ways with the ancestors of Neanderthals and Denisovans, Paabo said.

Klein said the comparisons might allow scientists to determine what makes our species unique and explain why we survive and others didn't.

Paabos group plans to publish a scientific paper later this year.

In the meantime, the genome sequence is being made freely available so scientists elsewhere can conduct research on it, he said.

The announcement was welcomed by other researchers.

More here:
Researchers publish improved Neanderthal genome

Posted in Genome | Comments Off on Researchers publish improved Neanderthal genome

Neanderthal Genome Data Sheds Light on Human Ancestors

Posted: at 4:44 pm

Scientists at Germany's Max Planck Institute have released a final version of a high-quality sequencing of a Neanderthal genome, which could shed light on why humans survived and earlier hominid species did not.

"The genome of a Neanderthal is now there in a form as accurate as that of any person walking the streets today," Svante Paabo, a geneticist, told the Associated Press. Paabo led the research project as part of the Institutes Evolutionary Anthropology department.

Neanderthals are the closest relative to humans and existed as recently as 30,000 years ago. It is believed by many scientists that modern humans, Homo sapiens, drove them to extinction. Humans and Neanderthals became divergent branches on the evolutionary tree more than 300,000 years ago.

The DNA for the sequencing came from a toe bone found in a Siberian cave is far more detailed than a previous "draft" Neanderthal genome sequenced three years ago by the same team.

The DNA confirmed speculation that humans, interbred with Neanderthals as they spread from the African plains to the Middle East and northern Africa, but that it happened about 80,000 years ago, much earlier than previously thought.

The research team hopes to compare the new genome sequence to that of other Neanderthals, modern humans and Denisovans, another extinct hominid group, the genome of which was extracted from remains in the same cave.

Wil Roebroeks, an archaeologist at Leiden University in the Netherlands who wasn't involved in the Leipzig study, told the AP it was "exciting times" for comparative studies of humans and our closest extinct relatives.

More:
Neanderthal Genome Data Sheds Light on Human Ancestors

Posted in Genome | Comments Off on Neanderthal Genome Data Sheds Light on Human Ancestors

DOE Joint Genome Institute 8th Annual Meeting on March 26-28, 2013

Posted: at 4:44 pm

Public release date: 21-Mar-2013 [ | E-mail | Share ]

Contact: David Gilbert degilbert@lbl.gov 925-296-5643 DOE/Joint Genome Institute

The 8th Annual Genomics of Energy and Environment Meeting of the U.S. Department of Energy Joint Genome Institute (DOE JGI) will be held at the Marriott in Walnut Creek on March 26-28, 2013. The talks will focus on genomics research in the fields of clean energy generation and the environment. Keynote speeches will be delivered by Eric Karsenti of European Molecular Biology Laboratory on "TARA OCEANS: A global analysis of oceanic plankton ecosystems" and Chris Voigt of MIT on "Part mining for synthetic biology."

For further information about the agenda, visit http://bit.ly/JGI-UM8-agenda. For more details and for free media registration, contact David Gilbert, DOE Joint Genome Institute Public Affairs Manager at degilbert@lbl.gov.

WHO: Researchers working in the fields of genomics, bioenergy, carbon cycling and biogeochemistry WHAT: 8th Annual Genomics of Energy & Environment Meeting WHERE: Marriott in Walnut Creek (2355 North Main Street, Walnut Creek, California 94596) WHEN: 5 pm, Tuesday, March 26, 2013 to 5 pm, Thursday, March 28, 2013

The annual meeting draws several hundred attendees from around the world. This year's talks and poster presentations will cover a wide range of topics in the fields of metagenomics, plants, microbial genomics and synthetic biology. Among the projects to be discussed are:

###

Since 2005, the DOE Joint Genome Institute has focused on the application of genomics to bioenergy and environmental issues. Organisms are selected for sequencing based on their relevance to the DOE missions, judged by an independent peer review process. Many of the projects focus on one of three key aspects: the development of biofuel feedstocks; the identification of enzymes that can effectively break down plant fibers into sugar; and the development of processes to ferment plant-derived sugars into liquid biofuel.

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

See the rest here:
DOE Joint Genome Institute 8th Annual Meeting on March 26-28, 2013

Posted in Genome | Comments Off on DOE Joint Genome Institute 8th Annual Meeting on March 26-28, 2013

German researchers publish full Neanderthal genome

Posted: at 4:44 pm

Researchers in Germany said Tuesday they have completed the first high-quality sequencing of a Neanderthal genome and are making it freely available online for other scientists to study.

The genome produced from remains of a toe bone found in a Siberian cave is far more detailed than a previous "draft" Neanderthal genome sequenced three years ago by the same team at the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany.

"This allows even the small differences between the copies of genes that this Neanderthal individual inherited from its mother and father to be distinguished," the institute said in a statement.

The team led by geneticist Svante Paabo now hopes to compare the new genome sequence to that of other Neanderthals, as well as to that of a Denisovan - another extinct human species whose genome was previously extracted from remains found in the same Siberian cave.

"We will gain insights into many aspects of the history of both Neanderthals and Denisovans and refine our knowledge about the genetic changes that occurred in the genomes of modern humans after they parted ways with the ancestors of Neanderthals and Denisovans," Paabo said. The group plans to publish a scientific paper on the issue later this year.

In the meantime, the genome sequence is being made freely available so scientists elsewhere can conduct research on it, he said.

The announcement was welcomed by other researchers.

Wil Roebroeks, an archaeologist at Leiden University in the Netherlands who wasn't involved in the Leipzig study, said it was "exciting times" for comparative studies of humans and our closest extinct relatives.

By combining findings from genetics with studies of early diets, technology and physical anthropology of different human species, scientists would likely yield new insights into our evolutionary past soon, he said.

More:
German researchers publish full Neanderthal genome

Posted in Genome | Comments Off on German researchers publish full Neanderthal genome

Have Researchers Computed the Complete Neanderthal Genome ?

Posted: at 4:44 pm

Three years ago, an international team of scientists, led by researchers at the Max Planck Institute for Evolutionary Anthropology, in Leipzig, Germany published the first draft of the Neanderthal genome. Now the German group says they have computed a much higher quality genome.

The first draft was decoded using DNA fragments collected from three different bone pieces. The researchers have generated the new version from one toe bone, so it represents the genome of a single Neanderthal individual. They plan to publish a scientific paper later this year, but have already made the entire sequence freely available online for other scientists.

Computing the DNA blueprint of an extinct species is no easy task. Sophisticated DNA sequencing and computing techniques helped the team put together the first draft of the roughly 3.2-billion base-pair long genome (about the size of a modern human genome).

One challenge is that DNA fragments from fossil bones are typically only about 50 bases long; once these fragments are sequenced, assembly algorithms sort through the short sequences and string them together into longer and longer sections. During sequencing, though, some base positions get sequenced multiple times and others are missed completely. In the 2010 draft version, each position was determined once on average. New sequencing techniques the group has developed over the past two years have allowed them to sequence every position in the genome 50 times on average.

Seeing each position that often dramatically reduces the chance that we make an error in the sequence, says Janet Kelso, a bioinformatics researcher at the Max Planck Institute. This 50-fold coverage Neanderthal genome is as good as, or better than the genomes that have been sequenced for many present-day humans.

Heres the caveat: when genomes are sequenced with next-generation sequencing technologies, some regions, typically those composed of highly repetitive sequences, simply cannot be confidently reconstructed, says Kelso. So these regions are generally not included in the final sequence.

Thats why this ARS Technica article boldly, and rightly, says that the Neanderthal genome is not complete even though its about as good as we can probably get with prehistoric genomes.

But as Kelso points out, the problem exists for all genomes, be they old or new. In this sense, I would argue that there is no complete human genomemodern or ancient!

Read more:
Have Researchers Computed the Complete Neanderthal Genome ?

Posted in Genome | Comments Off on Have Researchers Computed the Complete Neanderthal Genome ?

Eczema Nonprofit Seeks to Shine New Light on Overlooked Condition

Posted: at 4:44 pm

ITSAN: International Topical Steroid Addiction Network makes the case for the correlation between the worsening and spreading of eczema, and the overuse of topical steroids.

Indian Harbour Beach, Florida (PRWEB) March 21, 2013

In 30 years of practice I have seen over 2,000 patients who initially had eczema, either in youth, teen years or early adulthood. Each patient started off using cortisone creams. When the initial dose and potency no longer worked they were prescribed a higher potency with more frequent usage. In addition often pills and injections of cortisone were given, said Dr. Rapaport.

In all cases we decided to stop steroids and lo and behold, in one to three years, they were all cured. However, in each case the patient experienced a painful and debilitating withdrawal. They would swell, ooze, have difficulty functioning in school or work, scratch continually, and couldnt sleep; we had to support them with other medication and keep them off steroids, stated Dr. Rapaport.

Kelly Palace, president and Co-Founder of ITSAN, was diagnosed in 2009 with steroid induced eczema caused by her topical steroid addiction. Kelly decided to start a website to chronicle her recovery and alert people of the dangers associated with topical steroids. Since starting the site she has had over 100,000 web visits.

I was critically covered in full body eczema with no recourse. I was given corticosteroid after corticosteroid and told there was nothing else I could do. I was getting worse and worse until I found Dr. Rapaports articles; he saved my life, said ITSAN President Kelly Palace.

Kelly discovered thousands of people like her, over the Internet, suffering the same eczema like incurable symptoms. Whenever they stopped applying topical steroids, their skin would flare, burn, and turn red. Once we each discovered the research, which depicted these exact withdrawal symptoms, we knew our cure was in sight, said Kelly Palace.

ITSANs goals include educating eczema patients about this medical issue. Gaining more recognition amongst the broader medical community about topical steroid addiction. Labeling changes to topical steroids to better warn patients, and patient treatment options for a monitored and less painful withdrawal process.

Kelly Palace has high hopes for those who are still suffering. We hope that if youre suffering that you get the help and support you need from the ITSAN resources and our global, community support groups.

To learn more about Dr. Marvin Rapaport and his research on topical steroid addiction, please visit http://itsan.org.

See the rest here:
Eczema Nonprofit Seeks to Shine New Light on Overlooked Condition

Posted in Eczema | Comments Off on Eczema Nonprofit Seeks to Shine New Light on Overlooked Condition

Eczema hurts more than the skin

Posted: at 4:44 pm

Preet Bhogal still remembers being taunted in school for his inflamed skin. The Nova Scotia native would always wear long-sleeved shirts to cover his arms and tried to shrug off jeers about the flare-ups on his hands, but the words still hurt.

"My eczema covered just about my whole body," says the 33-year-old, who has lived with the skin condition since he was a baby. "It definitely affected my self image, self esteem, mental health."

While the physical severity of Bhogal's eczema improved with a combination of age and a strict care regime, its emotional impact continued to be felt in subtle ways. He didn't wear short-sleeved T-shirts until he was in his 20s, doesn't know how to swim because his eczema was exacerbated by pool water, and he vividly recalls how concerned some of his peers were about catching the skin condition that isn't contagious.

As the rates of those who experience the condition appear to be on the rise, Bhogal and advocates for those with the skin disease hope having conversations about eczema will help demystify the condition and make it easier to deal with.

"There's often a lack of awareness of the issues that it causes," says Bhogal, who is now a board member with the Canadian Skin Patient Alliance.

"I would like for people to just know that it exists and for people to not be afraid to talk about it."

While official statistics are rare, a number of doctors and patient support groups estimate about 20 per cent of Canadians will experience eczema at some point in their lives.

"When you talk about 20 per cent, that's huge," says Dr. Catherine McCuaig, a pediatric dermatologist at the Sainte-Justine children's hospital in Montreal.

Eczema exists in different forms and is most often experienced in childhood. One of the most common forms is atopic dermatitis, a hereditary condition which results in red, itchy and swollen skin which can have fluid-filled bumps that ooze and crust.

Another common form is contact dermatitis - where skin is inflamed from contact with an allergen, like poison ivy, or repeated exposure to an irritant. Other versions of eczema include a form associated with varicose veins and another related to dry skin.

See the article here:
Eczema hurts more than the skin

Posted in Eczema | Comments Off on Eczema hurts more than the skin

Ben-Gurion U. researchers and Teva Pharmaceutical Industries Ltd. develop psoriasis drug

Posted: at 4:43 pm

Public release date: 19-Mar-2013 [ | E-mail | Share ]

Contact: Andrew Lavin andrewlavin@alavin.com 516-944-4486 American Associates, Ben-Gurion University of the Negev

BEER-SHEVA, Israel, March 20, 2013 -- Ben-Gurion University of the Negev (BGU) researchers, in collaboration with Teva Pharmaceutical Industries Ltd., have developed a promising drug candidate to treat psoriasis. The finding was reported in a new paper published in Chemistry and Biology.

Psoriasis is a chronic, non-contagious disease characterized by inflamed lesions covered with silvery-white scabs of dead skin. An auto-immune disease, psoriasis affects at least four million Americans. It is caused by the disturbance in the natural balance between pro-inflammatory signals and signals that inhibit inflammation.

One of the key signals involved in the progression of psoriasis is the immune system protein Interleukin 17 (IL-17). The research team developed a method to inhibit IL-17 pro-inflammatory signals and proved that their engineered receptor, IL-17R, is highly effective in reducing IL-17 induced inflammatory signals in mice models. Moreover, injection of the receptor into a mouse model with acute human psoriasis eliminated the symptoms, essentially curing the disease.

"Using directed evolution to improve the properties of the IL-17 receptor, we have created engineered mutants that might prove there is a viable treatment for patients with severe psoriasis that do not respond to current drugs," explains Dr. Amir Aharoni, one of the researchers in BGU's Department of Life Sciences and the National Institute for Biotechnology in the Negev.

"Since the directed evolution method can be applied to other receptors involved in autoimmune diseases and cancer, I believe that we are just starting to unravel the potential of this approach," Aharoni adds.

Directed evolution is an iterative Darwinian optimization process used in protein engineering whereby the fittest variants are selected from a collection of random mutations. Improved variants are identified and isolated by screening or selection for the property of interest. This approach is particularly advantageous in cases in which no prior knowledge of a protein's mechanism and structure is available.

The other researchers credited in "Directed Evolution of a Soluble Human IL-17A Receptor for the Inhibition of Psoriasis Plaque Formation in a Mouse Model" are BGU's Dr. Marianna Zaretsky and Teva researchers Dr. Liora Sklair-Tavron, Dr. Joel Kaye and Revital Etzyoni.

###

Follow this link:
Ben-Gurion U. researchers and Teva Pharmaceutical Industries Ltd. develop psoriasis drug

Posted in Psoriasis | Comments Off on Ben-Gurion U. researchers and Teva Pharmaceutical Industries Ltd. develop psoriasis drug

Team develops psoriasis drug

Posted: at 4:43 pm

Ben-Gurion University of the Negev (BGU) researchers, in collaboration with Teva Pharmaceutical Industries Ltd., have developed a promising drug candidate to treat psoriasis. The finding was reported in a new paper published in Chemistry and Biology.

Psoriasis is a chronic, non-contagious disease characterized by inflamed lesions covered with silvery-white scabs of dead skin. An auto-immune disease, psoriasis affects at least four million Americans. It is caused by the disturbance in the natural balance between pro-inflammatory signals and signals that inhibit inflammation.

One of the key signals involved in the progression of psoriasis is the immune system protein Interleukin 17 (IL-17). The research team developed a method to inhibit IL-17 pro-inflammatory signals and proved that their engineered receptor, IL-17R, is highly effective in reducing IL-17 induced inflammatory signals in mice models. Moreover, injection of the receptor into a mouse model with acute human psoriasis eliminated the symptoms, essentially curing the disease.

"Using directed evolution to improve the properties of the IL-17 receptor, we have created engineered mutants that might prove there is a viable treatment for patients with severe psoriasis that do not respond to current drugs," explains Dr. Amir Aharoni, one of the researchers in BGU's Department of Life Sciences and the National Institute for Biotechnology in the Negev.

"Since the directed evolution method can be applied to other receptors involved in autoimmune diseases and cancer, I believe that we are just starting to unravel the potential of this approach," Aharoni adds.

Directed evolution is an iterative Darwinian optimization process used in protein engineering whereby the fittest variants are selected from a collection of random mutations. Improved variants are identified and isolated by screening or selection for the property of interest. This approach is particularly advantageous in cases in which no prior knowledge of a protein's mechanism and structure is available.

The other researchers credited in "Directed Evolution of a Soluble Human IL-17A Receptor for the Inhibition of Psoriasis Plaque Formation in a Mouse Model" are BGU's Dr. Marianna Zaretsky and Teva researchers Dr. Liora Sklair-Tavron, Dr. Joel Kaye and Revital Etzyoni.

Journal reference: Chemistry & Biology

Provided by American Associates, Ben-Gurion University of the Negev

View original post here:
Team develops psoriasis drug

Posted in Psoriasis | Comments Off on Team develops psoriasis drug

Fracking film maker accuses IMF of censorship

Posted: at 4:43 pm

The maker of a documentary in support of oil and gas fracking has accused the International Monetary Fund of censorship after it declined to show a key clip from his film at a conference.

Phelim McAleer, whose film FrackNation argues in support of the controversial exploration technique, said the IMF was afraid of offending Russia by letting him show the clip at the conference this week.

The clip suggests that allowing fracking in Eastern European countries such as Poland would ease the region's dependence on imported energy.

It alleges that powerful gas exporter Russia was financing the anti-fracking movement to protect its sales.

"Basically they were censoring my presentation, they were censoring my speech," said McAleer.

"They're trying to force people not to say terrible things because it could offend one of their senior members," he told AFP. "They didn't want to offend Russia."

McAleer had been invited to make a presentation at lunch on Wednesday, the first day of the two day joint IMF-Oxford University conference in Washington on commodity prices.

But he decided not to attend after the IMF said in an email that it could not permit the clip on Russia and Poland "without allowing others to have their say on the matter".

"Since that isn't possible on this occasion, Phelim will have to skip that," it said in the email, viewed by AFP.

The IMF said it welcomed McAleer showing other excerpts from his documentary.

See the original post here:
Fracking film maker accuses IMF of censorship

Posted in Censorship | Comments Off on Fracking film maker accuses IMF of censorship

Page 4,753«..1020..4,7524,7534,7544,755..4,7604,770..»